PL EN
 
2015 vol. 69
Get citation
Anti-inflammatory microglial cell function in the light of the latest scientific research
Krzysztof Łabuzek 1
,
 
Edyta Skrudlik 1
,
 
Bożena Gabryel 1
,
 
Bogusław Okopień 1
 
 
 
More details
Hide details
1
Katedra Farmakologii Śląskiego Uniwersytetu Medycznego w Katowicach
 
 
Corresponding author
Krzysztof Łabuzek   

Katedra Farmakologii Śląskiego Uniwersytetu Medycznego w Katowicach, ul. Medyków 18, 40-752 Katowice, tel. +48 503 067 376
 
 
Ann. Acad. Med. Siles. 2015;69:99-110
DOI: https://doi.org/10.18794/aams/32608
 
 
Article (PDF)
References (53) Citations (4)
 
KEYWORDS
microglia
fractalkine
alternative activation
CD200
IL-1
IL-6
TNF
TGF
 
TOPICS
Medical Biology
Physiology
Histology
 
ABSTRACT
Microglia represent the immune system in the central nervous system. They have long been regarded as as the main aggressor, which induce and support inflammatory and neurodegenerative processes in the central nervous system. The latest studies indicate that they can also play a protective role. In this study we present evidence underlying their anti-inflammatory properties. Microglia can be activated in two different ways and they have two different phenotypes: classical – pro-inflammatory and alternative – anti-inflammatory. The latter is characterized by CD200 expression and fractalkine. Alternatively, the activated microglia also produce pro-inflammatory cytokine. Their influence on the surrounding cells is associated not only with destruction but also with neuroregeneration and myelination. Perhaps the latest reports will draw researchers' attention to new solutions which may be used in the prevention and treatment of the central nervous system diseases through the anti-inflammatory properties of cells which are still seen as inflammatory cells.
 
REFERENCES (53)
1.
Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of Microglia. Glia 1993; 7(1): 111–118.
Google Scholar
 
 
2.
McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., McGeer E.G. Microglia in Degenerative Neurological Disease. Glia 1993; 7(1): 84–92.
Google Scholar
 
 
3.
Rozenmuller J.M., Valk P. van der, Eikelenboom, P. Activated microglia and cerebral amyloid deposits in Alzheimer’s disease. Res. Immunol. 1992; 143: 646–650.
Google Scholar
 
 
4.
Giulian D., Baker T.J. Characterization of Ameboid Microglia Isolated from Developing Mammalian Brain. J. Neurosci. 1986; 6: 2163–2178.
Google Scholar
 
 
5.
Ghorpade A., Gendelman H.E., Kipins J. Macrophages, Microglia and Dendritic Cells. In: Neuroimmune Pharmacology. Eds. Ikezu T., Gendelman H.E. Springer, USA 2008, 89–100.
Google Scholar
 
 
6.
Chan W.Y., Kohsaka S., Rezaie P. The origin and cell lineage of microglia – New concepts. Brain Res. Rev. 2007; 53: 344–354.
Google Scholar
 
 
7.
Ling E.A., Wong W.C. The origin and nature of ramified and amoeboid microglia: A historical review and current concepts. Glia 1993; 7: 9–18.
Google Scholar
 
 
8.
Boya J., Calvo J.L., Carbonell A.L., Borregon A. A lectin histochemistry study on the development of rat microglial cells. J. Anat. 1991; 175: 229–236.
Google Scholar
 
 
9.
Moskalewski S. Tkanka nerwowa. W: Stevens A., Lowe J. Histologia człowieka. PZWL, Warszawa 2000, 77–98.
Google Scholar
 
 
10.
Kaur C., Hao A.J., Wu C.H., Ling E.A. Origin of Microglia. Microsc. Res. Tech. 2001; 54: 2–9.
Google Scholar
 
 
11.
Ling E.A., Tan C.K. Amobeoid microglial cells in the corpus callosum of neonatal rats. Arch. Histol. Jpn. 1974; 36: 265–280.
Google Scholar
 
 
12.
Stokłosa T. Psychoneuroimmunologia. W: Jakóbisiak M. Immunologia. PWN, Warszawa 1998, 387–398.
Google Scholar
 
 
13.
Kettnemann H., Banati R., Walz W. Electrophysiological Behavior of Microglia. Glia 1993; 7: 93-101.
Google Scholar
 
 
14.
Cameron B., Landreth G.E. Inflammation, microglia, and Alzheimer’s disease. Neurobiol. Dis. 2010; 37: 503–509.
Google Scholar
 
 
15.
Becher B., Prat A., Antel J.P. Brain – Immune Connection: Immuno-Regulatory Properties of CNS – Resident Cells. Glia 2000; 29: 293–304.
Google Scholar
 
 
16.
Gehrmann J., Gold R., Linington Ch., Lannes-Vieira J., Wekerle H., Kreutzberg G.W. Microglial Involvement in Experimental Autoimmune Inflammation of the Central and Peripheral Nervous System. Glia 1993; 7: 50–59.
Google Scholar
 
 
17.
Theele D.P., Streit W.J. A Chronicle of Microglial Ontogeny. Glia 1993; 7: 5–8.
Google Scholar
 
 
18.
Kohman R.A., Rhodes J.S. Neurogenesis, inflammation and behavior. Brain Behav. Immun. 2013; 27C; 22–32.
Google Scholar
 
 
19.
Hanamsagar R., Torres V., Kielian T. Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia. J. Neurochem. 2011; 119: 736–748.
Google Scholar
 
 
20.
Sawada H., Hishida R., Hirata Y. i wsp. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurosci. Res. 2007; 85: 1752–1761.
Google Scholar
 
 
21.
Cao T., Thomas T.C., Ziebell J.M., Pauly J.R., Lifshitz J. Morphological And Genetic Activation Of Microglia After Diffuse Traumatic Brain Injury in the Rat. Neuroscience 2012; 225: 65–75.
Google Scholar
 
 
22.
Karlstetter M., Walczak Y., Weigelt K. i wsp. The Novel Activated Microglia/Macrophage WAP Domain Protein, AMWAP, Acts as a Counter-Regulator of Proinflammatory Response. J. Immunol. 2010; 185: 3379–3390.
Google Scholar
 
 
23.
Tansey M.G., Goldberg M.S. Neuroinflammation in Parkinsons disease – It's role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 2010; 37: 510–518.
Google Scholar
 
 
24.
Napoli I., Neumann H. Protective effects of microglia in multiple sclerosis. Exp. Neurol. 2010; 225(1): 24–28.
Google Scholar
 
 
25.
Schwartz M., Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat. Rev. Neurol. 2010; 6: 405–410.
Google Scholar
 
 
26.
Ma T.C., Buescher J.L., Oatis B. i wsp. Metformin therapy in a transgenic mouse model of Huntington's disease. Neurosci. Lett. 2007; 411: 98–103.
Google Scholar
 
 
27.
Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 2006; 27; 3: 27.
Google Scholar
 
 
28.
Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effectors cells in the normal and pathologic brain. Nat. Neurosci. 2007; 10: 1387–1394.
Google Scholar
 
 
29.
Heneka M.T., Kummer M.P., Stutz A. i wsp. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 2013; 493: 674–678.
Google Scholar
 
 
30.
Cerbai F., Lana D., Nosi D. i wsp. The Neuron-Astrocyte-Microglia Triad in Normal Brain Ageing and in a Model of Neuroinflammation in the Rat Hippocampus. PLoS One 2012; 7: e45250.
Google Scholar
 
 
31.
Lucin K.M., O’Brien C.E., Bieri G. i wsp. Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s Disease. Neuron 2013; 79: 873–886.
Google Scholar
 
 
32.
Labuzek K., Gabryel B., Okopień B. Metformin as a key to alternative activation of microglia? Postepy Hig. Med. Dosw. (online) 2014; 68: 247–257.
Google Scholar
 
 
33.
Yi M.H., Zhang E., Kanq J.W. i wsp. Expression of CD200 in alternative activation of microglia following an excitotoxic lesion in the mouse hippocampus. Brain Res. 2012; 1481: 90–96.
Google Scholar
 
 
34.
Varnum M.M., Ikezu T. The classification of microglia Activation phenotypes on neurodegeneration and regeneraion in Alzheimer's disease. Arch. Immunol. Ther. Exp. (Warsz) 2012; 60(4): 251–266.
Google Scholar
 
 
35.
Pabon M.M., Bachstetter A.D., Hudson C.E., Gemma C., Bickford P.C. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J. Neuroinflammation 2011; 8: 9.
Google Scholar
 
 
36.
Owłasiuk P., Zajkowska J.M., Pietruczuk M., Pancewicz S.A., Hermanowska-Szpakowicz T. Fraktalkina – budowa, własności i biologiczna rola. Pol. Merkuriusz Lek. 2009; 26(153): 253–257.
Google Scholar
 
 
37.
Cipriani R., Villa P., Chece G. i wsp. CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents. J. Neurosci. 2011; 31: 16327–16335.
Google Scholar
 
 
38.
Spittau B., Wullkopf L., Zhou X., Rilka J., Pfeifer D., Krieglstein K. Endogenous Transforming Growth Factor-Beta Promotes Quiescence of Primary Microglia in Vitro. Glia 2013; 61: 287–300.
Google Scholar
 
 
39.
Zhou X., Spittau B., Krieglstein K. TGF beta signalling plays an important role in Il-4-induced alternative activation of microglia. J. Neuroinflammation 2012; 9: 210.
Google Scholar
 
 
40.
Sato A., Ohtaki H., Tsumuraya T. i wsp. Il-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury. J. Neuroinflammation 2012; 9: 65.
Google Scholar
 
 
41.
Matousek S.B., Ghosh S., Shaftel S.S., Kyrkanides S., Olschowka J.A., O'Banion M.K. Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration. J. Neuroimmune Pharmacol. 2012; 7: 156–164.
Google Scholar
 
 
42.
Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 2012; 8: 1237–1247.
Google Scholar
 
 
43.
Erta M., Quintana A., Hidalgo J. Interleukin-6, a Major Cytokine in the Central Nervous System. Int. J. Biol. Sci. 2012; 8: 1254–1266.
Google Scholar
 
 
44.
Islam O., Gong X., Rose-John S., Heese K. Interleukin-6 and Neural Stem Cells: More Than Gliogenesis. Mol. Biol. Cell. 2009; 20: 188–199.
Google Scholar
 
 
45.
Swartz K.R., Liu F., Sewell D. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 2001; 896: 86–95.
Google Scholar
 
 
46.
Jung J.E., Kim G.S., Chan P.H. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 2011; 42: 3574–3579.
Google Scholar
 
 
47.
Biber K., Pinto-Duarte A., Wittendorp M.C. Interleukin-6 upregulates neuronal adenosine A1 receptors implications for neuromodulation and neuroprotection. Neuropsychopharmacology 2008; 33: 2237–2250.
Google Scholar
 
 
48.
Calmon-Hamaty F., Combe B., Hahne M., Morel J. Lymphotoxin α revisited: general features and implications in rheumatoid arthritis. Arthritis Res. Ther. 2011; 13: 232.
Google Scholar
 
 
49.
Park K.M., Bowers W.J. TNFa mediated signaling in neuronal homeostasis and dysfunction. Cell Signal. 2010; 22: 977–983.
Google Scholar
 
 
50.
Carlson N.G., Wieggel W.A., Chen J., Bacchi A., Rogers S.W., Gahring L.C. Inflammatory Cytokines IL-1a, IL-1b, IL-6, and TNF-a Impart Neuroprotection to an Excitotoxin Through Distinct Pathways. J. Immunol. 1999; 163: 3963–3968.
Google Scholar
 
 
51.
Widera D., Holtkamp W., Entschladen F. i wsp. MCP-1 induces migration of adult neural stem cells. Eur. J. Cell. Biol. 2004; 83: 381–387.
Google Scholar
 
 
52.
Gonzalez-Perez O., Jauregui-Huerta F., Galvez-Contreras A.Y. Immune system modulates the function of adult neural stem cells. Curr. Immunol. Rev. 2010; 6: 167–173.
Google Scholar
 
 
53.
Montgomery S.L., Mastrangelo M.A., Habib D. i wsp. Ablation of TNF-RI/RII Expression in Alzheimer's Disease Mice Leads to an Unexpected Enhancement of Pathology Implications for Chronic Pan-TNF-α Suppressive Therapeutic Strategies in the Brain. Am. J. Pathol. 2011; 179: 2053–2070.
Google Scholar
 
 
 
CITATIONS (4):
1.
Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
Ewelina Palasz, Wiktor Niewiadomski, Anna Gasiorowska, Adrianna Wysocka, Anna Stepniewska, Grazyna Niewiadomska
Frontiers in Neurology
 
CrossRef
 
 
2.
The Role of Dietary Antioxidants in the Pathogenesis of Neurodegenerative Diseases and Their Impact on Cerebral Oxidoreductive Balance
Anna Winiarska-Mieczan, Ewa Baranowska-Wójcik, Małgorzata Kwiecień, Eugeniusz Grela, Dominik Szwajgier, Katarzyna Kwiatkowska, Bożena Kiczorowska
Nutrients
 
CrossRef
 
 
3.
The Immunomodulary Effects of Systematic Exercise in Older Adults and People with Parkinson’s Disease
Jadwiga Szymura, Jadwiga Kubica, Magdalena Wiecek, Joanna Pera
Journal of Clinical Medicine
 
CrossRef
 
 
4.
Neuroplasticity and Neuroprotective Effect of Treadmill Training in the Chronic Mouse Model of Parkinson’s Disease
Ewelina Palasz, Wiktor Niewiadomski, Anna Gasiorowska, Anna Mietelska-Porowska, Grazyna Niewiadomska
Neural Plasticity
 
CrossRef
 
 
Share
Send by email
RELATED ARTICLE
Evaluation of IL-6 secretion by colon cancer cells treated with phytic acid
Indexes
 
Keywords index
Topics index
Authors index
eISSN:1734-025X
Journals System - logo


© 2006-2024 Journal hosting platform by Bentus
Scroll to top